학술논문
A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancer
Document Type
Article
Author
Source
In: Proceedings of the National Academy of Sciences of the United States of America . (Proceedings of the National Academy of Sciences of the United States of America, 2024, 121(4))
Subject
Language
English
ISSN
10916490
00278424
00278424